We suggest keeping a simple diary for 24 weeks, noting: Energy Levels: Are you tired all the time, or just after your injection
6000 /
Effectiveness of the iron chelator CN128 in mitigating the formation of dopamine oxidation products associated with the progression of parkinsons disease
Location: Indianapolis, IndianaWarning Letter Date: September 9, 2025FDA Department Issuing Warning: Center for Drug Evaluation and Research (CDER)Type of Warning: False & Misleading Claims/Misbranded DrugsSubject of Violation: An Oprah Special: Shame, Blame, and the Weight Loss Revolution, regarding Zepbound (tirzepatide) and Mounjaro (tirzepatide)FDA Warning: In the program, which aired on television in 2024 and until recently was available continuously on the ABC website and through various streaming services, Eli Lilly promoted Mounjaro and Zepbound in a manner that failed to present the serious risks of these drug products in a truthful and nonmisleading manner, despite FDAs prior correspondence (advisory comments dated June 13, 2022 and June 21, 2022)
We still need to have CPAP as our first line, but this is supportive of what we're experiencing. GLP-1 drugs probably help peoples sleep apnea by helping them lose fat, Wohlberg said